Brandywine Hospital offering new COVID-19 treatment
Brandywine Hospital – Tower Health received doses of the recently approved COVID-19 drug bamlanivimab, a monoclonal antibody to treat individuals diagnosed with COVID-19. The drug, developed by Eli Lilly, was approved by the FDA for patients 12 years and older under “emergency use authorization,” according to a press release This status allows new medications that have passed general safety tests and have preliminarily demonstrated effectiveness…
